A Study to Assess the Effects of Single Ascending Doses of ASP1707 in Healthy Young Japanese Male Subjects
PHASE1CompletedINTERVENTIONAL
Enrollment
24
Participants
Timeline
Start Date
June 30, 2011
Primary Completion Date
August 31, 2011
Study Completion Date
August 31, 2011
Conditions
Healthy Subjects
Interventions
DRUG
ASP1707
oral
DRUG
Placebo
oral
Trial Locations (1)
HA1 3UJ
Parexel Early Phase, Harrow
All Listed Sponsors
lead
Astellas Pharma Europe B.V.
INDUSTRY
NCT02146742 - A Study to Assess the Effects of Single Ascending Doses of ASP1707 in Healthy Young Japanese Male Subjects | Biotech Hunter | Biotech Hunter